| 摘要 |
The present inventions relates to a process for the selection of anti c-Met antibodies capable to inhibit both ligand-dependant and ligand-independent activation of c-Met. More particularly, said process is based on the inhibition of the c-Met dimerization. In another aspect, the present invention concerns such antibodies and compositions comprising such antibodies for the preparation of a medicament to treat cancer. Diagnosis process and kits are also part of the invention. |
